LSTA · Company research
Lisata Therapeutics, Inc. Common Stock (LSTA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Lisata Therapeutics Expands Board, Appoints Independent Director - The Globe and Mail | Lisata Therapeutics Expands Board, Appoints Independent Director The Globe and Mail | View source ↗ | The Globe and Mail | Oct 15, 2026 | neutral | 0 | 0.6 |
| A drug-company finance leader with more than 15 years in finance joins Lisata's board - Stock Titan | A drug-company finance leader with more than 15 years in finance joins Lisata's board Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| A new cancer-treatment patent adds market exclusivity into 2043, Lisata says. - Stock Titan | A new cancer-treatment patent adds market exclusivity into 2043, Lisata says. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Lisata Therapeutics, Inc. (LSTA) Stock Price, News, Quote & History - Yahoo! Finance Canada | Lisata Therapeutics, Inc. (LSTA) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 5, 2026 | neutral | 0 | 0.6 |
| A rare hormone disorder trial doses its first patient; its drug may allow shots every two weeks, not daily. - Stock Titan | A rare hormone disorder trial doses its first patient; its drug may allow shots every two weeks, not daily. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Halper Sadeh LLC is Investigating Whether BWIN, LSTA, ACVA are Obtaining Fair Deals for their Shareholders | Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. Baldwin Group (BWIN) is being sold for $32.50 per share, Lisata Therapeutics (LSTA) for $4.00 per share plus contingent value rights, and ACV for $10.50 per share. The firm is seeking increased consideration and additional disclosures on behalf of shareholders. | View source ↗ | GlobeNewswire Inc. | Oct 4, 2026 | bearish | -1 | 1 |
| With $0 left to sell, Lisata Therapeutics (LSTA) reports an exempt offering. - Stock Titan | With $0 left to sell, Lisata Therapeutics (LSTA) reports an exempt offering. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Lisata director holds preferred tied to 2.27M shares - Stock Titan | Lisata director holds preferred tied to 2.27M shares Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Lisata COO Holds Preferred Stock Tied to 2.54M Shares - Stock Titan | Lisata COO Holds Preferred Stock Tied to 2.54M Shares Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Lisata Therapeutics (LSTA) Buys Marea and Signs $225M Financing. Is the Dilution Worth it? - Yahoo Finance | Lisata Therapeutics (LSTA) Buys Marea and Signs $225M Financing. Is the Dilution Worth it? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 22, 2026 | neutral | 0 | 0.6 |
| Lisata Therapeutics (LSTA) Slides 2.48% as Biotech Stock Holds Key Support - Breakaway Gap - www.dars.gov.et | Lisata Therapeutics (LSTA) Slides 2.48% as Biotech Stock Holds Key Support - Breakaway Gap www.dars.gov.et | View source ↗ | www.dars.gov.et | Aug 13, 2026 | neutral | 0 | 0.6 |
| Lisata Therapeutics (LSTA) Drops 4.24% to $1.13, Approaching Critical Support - Rectangle Pattern - dars.gov.et | Lisata Therapeutics (LSTA) Drops 4.24% to $1.13, Approaching Critical Support - Rectangle Pattern dars.gov.et | View source ↗ | dars.gov.et | Aug 13, 2026 | neutral | 0 | 0.6 |
| Lisata Therapeutics Stock Falls After Hours: Here's Why - Benzinga | Lisata Therapeutics Stock Falls After Hours: Here's Why Benzinga | View source ↗ | Benzinga | Jul 22, 2026 | neutral | 0 | 0.6 |
| Lisata Therapeutics (LSTA) Sees Modest Uptick as Stock Tests Resistance Near $3.52 - Donchian Channel - po-news-eg.net | Lisata Therapeutics (LSTA) Sees Modest Uptick as Stock Tests Resistance Near $3.52 - Donchian Channel po-news-eg.net | View source ↗ | po-news-eg.net | Jul 6, 2026 | neutral | 0 | 0.6 |
| Lisata Therapeutics Announces Acquisition by Kuva Labs Inc. with $5.00 Cash Offer per Share | LSTA Stock News - Quiver Quantitative | Lisata Therapeutics Announces Acquisition by Kuva Labs Inc. with $5.00 Cash Offer per Share | LSTA Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Mar 6, 2026 | neutral | 0 | 0.6 |
| Lisata Shares Nearly Double On Buyout Offer: Here Are The Details - Stocktwits | Lisata Shares Nearly Double On Buyout Offer: Here Are The Details Stocktwits | View source ↗ | Stocktwits | Jan 21, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Apr 13, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.